Galenika pharmaceutical company was founded in 1945. After privatization in November 2017, it became part of the NC Group (www.gruponc.net.br), one of the largest pharmaceutical company in Latin America. Galenika produces generic drugs, dietary supplements, medical products and products for everyday use. The strategy of the new owner is the development of Galenika as a modern and flexible company, focused on research and development, which is constantly working to improve its products for improving health and quality of life, to the satisfaction of users.